Rajput Manoj Kumar
National Institute of Biologicals, India.
AIMS Microbiol. 2020 Oct 27;6(4):401-421. doi: 10.3934/microbiol.2020024. eCollection 2020.
Immunization programmes against hepatitis-B are being carried out since more than three decades but still HBV is a major public health problem. Hepatitis B virus (HBV) genome consists of circular and partial double stranded DNA. Due to partial double stranded DNA, it uses an RNA intermediate during replication. This replicative strategy of HBV and lack of polymerase proofreading activity give rise to error occurrences comparable to retroviruses. The low fidelity of polymerase, overlapping reading frames and high replication rate produces many non-identical variants at every cycle of replication. Therefore, HBV spreads with mutations and variations. The mutations have been reported both in non-structural as well as structural genes of HBV genome. Recent advances in molecular biology have made easier to analyse these mutations. Hepatitis B antiviral therapy and immunization are all influenced by genetic variability. The analysis and understanding of these mutations are important for therapy against hepatitis B and updating of diagnostic tools. The present review discusses about mutations occurring in whole HBV genome. The mutation occurring both in structural and non-structural genes and non-coding regions have been described in details. It is much more informative because most of literature available, covers only individual gene or DNA regions of HBV.
三十多年来一直在开展乙肝免疫计划,但乙肝病毒(HBV)仍是一个主要的公共卫生问题。乙肝病毒(HBV)基因组由环状和部分双链DNA组成。由于是部分双链DNA,它在复制过程中使用RNA中间体。HBV的这种复制策略以及缺乏聚合酶校对活性导致出现与逆转录病毒相当的错误。聚合酶的低保真性、重叠阅读框和高复制率在每个复制周期都会产生许多不同的变体。因此,HBV伴随着突变和变异传播。已报道在HBV基因组的非结构基因和结构基因中均有突变。分子生物学的最新进展使分析这些突变变得更加容易。乙肝抗病毒治疗和免疫都受基因变异性的影响。对这些突变的分析和理解对于乙肝治疗及更新诊断工具很重要。本综述讨论了整个HBV基因组中发生的突变。详细描述了结构基因、非结构基因和非编码区中发生的突变。这篇综述提供了更多信息,因为现有的大多数文献仅涵盖HBV的单个基因或DNA区域。